-
HSBC’s mid-year report signaled the challenges that many small and mid-sized biotech companies have shared; first financings declined in Q2 of 2025 and entrepreneurs and companies have had to make tou ...Educational Session Pompeii Ballroom
-
The pace of US biotech IPOs stalled for much of 2025 but reductions in interest rates corelate with an uptick in new offerings as investors reconsider the risks and returns from new medicines in this ...Educational Session Pompeii Ballroom
-
Alternative investors such as Ares Specialty Healthcare and Blackstone Life Sciences are providing management teams with options for non-dilutive capital to support M&A and R&D to compliment or substi ...Educational Session Ballroom II C
-
Company PresentationPerseo Pharma is a biopharmaceutical company pioneering innovative metabolic therapies. The company has raised USD 12 million from private investors, including a U.S. patient advocacy organization and ...Company Presentation
- Metabolic Diseases
-
Company PresentationXM Therapeutics is a Brown University spinoff developing tissue repair and regeneration therapies for chronic disorders where an impaired healing response leads to progressive fibrosis (scarring), inf ...Company Presentation
- Multiple Therapeutics
-
Company PresentationA clinical stage company developing a sustained-release drug delivery platform with broad applications. Our first product, ST-01, has successfully completed its Phase II trial and is moving towards a ...Company Presentation
- Multiple Therapeutics
-
Company PresentationBased in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-de ...Company Presentation
- Gene/Cell Therapy
-
Company PresentationOncolytics is developing pelareorep, the only dsRNA REO virus being developed as an immunotherapy treatment for various tumors, including KRAS mutant MSS mCRC and 2L anal cancer. Pelareorep has achiev ...Company Presentation
- Oncology
-
As the policy environment in Washington continues to evolve, biotech leaders are seeking clarity on implications for R&D, investment, and patient access. This briefing will cover developments at FDA, ...Educational Session Pompeii Ballroom
-
Company PresentationAIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of infectious disease and treatment of cancer. We take a unique pan-antigenic approach for our cancer v ...Company Presentation
- Oncology
-
Company PresentationResolution Therapeutics is a clinical stage pioneer in Regenerative Macrophage Therapies (RMT) for Inflammatory and Fibrotic Diseases. CLINICAL PROGRAM / HIGH UNMET NEED - EMERALD/OPAL (P1/2) for End ...Company Presentation
- Gene/Cell Therapy
-
Company PresentationInterAct Therapeutics (IAT) is a preclinical company advancing its proprietary InterAct Print™ platform to deliver transformative gene therapies for metastatic cancers. Our lead candidate, IAT-S2, tar ...Company Presentation
- Oncology
-
Company PresentationRakuten Medical is a clinical and commercial-stage biotech advancing its Alluminox™ photoimmunotherapy platform, which combines a drug and device to treat cancers. Its lead asset, ASP-1929, an EGFR-ta ...Company Presentation
- Oncology
-
Company PresentationTessera Therapeutics is pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Our mission is to cure disease ...Company Presentation
- Multiple Therapeutics
-
The Innovation Stage offers a mix of programming showcasing Florida talent, R&D, and investment and innovative biotech companies seeking breakthrough treatments.Innovation Stage
-
As biotech companies compete for talent, capital, and speed to value, geographic strategy has become a source of competitive advantage. South Florida has experienced an influx of seasoned operators, r ...Innovation Stage
-
Company PresentationThe production of high-quality mammalian cells remains a bottleneck, limiting productivity across the biomedical R&D landscape—from basic research to translational sciences, and therapeutics manufactu ...Company Presentation
- Tools/Drug Development Support Tech
-
Company PresentationKYAN Technologies is a functional precision medicine platform company dedicated to revolutionizing cancer care through our platform Optim.AI. This powerful tool empowers oncologists by providing them ...Company Presentation
- Diagnostics
-
Ironfist Therapeutics is advancing a new class of nanomedicine radiopharmaceuticals that selectively target tumor associated macrophages. Our precision medicine approach to treat any tumor with TAMs h ...Innovation Stage Session
- Oncology
-
While deal volumes have adjusted following the influx of capital during the pandemic, there has still been significant activity as pharma continues to assess overall strategy and biotech companies see ...Educational Session Pompeii Ballroom
-
Life Bio is a clinical-stage [SR3.1]biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. The company’s proprietary Partial Epigenetic Rep ...Innovation Stage Session
- Ophthalmology
-
7 Hills Pharma is a clinical-stage company advancing first-in-class small molecules leveraging a novel mechanism of action, pioneered by 7HP founders, to safely enhance the effectiveness of immunother ...Innovation Stage Session
- Oncology
-
Immunis is a clinical-stage biotechnology company at the forefront of regenerative and longevity medicine, developing health-focused therapeutics for age and immune-mediated muscle and metabolic disea ...Innovation Stage Session
- Regenerative Medicine
-
Expansion in the target landscape, from TL1A and beyond, has accelerated progress in I&I drug development with multibillion-dollar M&A across the past two years attracting more funding for programs in ...Educational Session Pompeii Ballroom
-
The Innovation Stage offers a mix of programming showcasing biotech companies seeking breakthrough treatments and the University of Florida.Innovation Stage
-
Company PresentationNewron is a biopharmaceutical company, headquartered in Bresso near Milan, Italy, the Company has a strong track record of advancing neuroscience-based treatments from discovery to market. Newron’s le ...Company Presentation
- CNS/Neurological
-
RESTEM is a leading clinical-stage biotechnology company focused on developing off-the-shelf, next-generation cell therapies for autoimmune, inflammatory, and age-related diseases. Leveraging propriet ...Innovation Stage Session
- Immunology
-
Company PresentationProMIS is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development and progression of n ...Company Presentation
- CNS/Neurological
-
Company PresentationConsano Bio is a clinical-stage biotechnology company advancing a novel therapeutic designed to address serious pain conditions where conventional therapies are limited or ineffective. Its lead invest ...Company Presentation
- Regenerative Medicine
-
Company PresentationGATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% se ...Company Presentation
- Tools/Drug Development Support Tech
-
IMMEDIATE Therapeutics is a late-stage biotech company developing IMT-358, a first-in-class cardioprotective metabolic therapy for use in acute coronary syndromes (ACS), high-risk surgeries, trauma, a ...Innovation Stage Session
- Cardiovascular
-
Company PresentationAlphyn Biologics, Inc. is advancing breakthrough therapies for skin diseases using its patented drug platform for first-in-class Multi-Target Therapeutics®. The company's platform technology is an inn ...Company Presentation
- Dermatology
-
Company PresentationQuantum-ready, AI-native drug-discovery platform with first-in-class anti-infective & metabolic peptides, $8.7m+ non-dilutive funding locked in, and a patent estate already battle-tested against a US ...Company Presentation
- Tools/Drug Development Support Tech
-
Company PresentationAzitra is a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. Azitra's lead program, ATR-12, uses an engineered strain of S. epidermidis de ...Company Presentation
- Dermatology
-
Company PresentationABOUT INNOPATH InnoPath Therapeutics is a pre-clinical-stage dermatologic oncology company developing next-generation topical treatments for actinic keratosis (AK) and non-melanoma skin cancer (NMSC)— ...Company Presentation
- Dermatology
-
GLP-1 analogs have rewritten treatment standards and changed patients’ expectations related to obesity, yet even more tantalizing is growing evidence they could hold the key to broader improvements in ...Educational Session Pompeii Ballroom
-
Company PresentationHalia Therapeutics is a clinical-stage biotechnology company developing first-in-class therapies that target inflammation at its source. Our pipeline is built on a deep understanding of genetic resili ...Company Presentation
- Inflammation
-
Company PresentationJupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company focused on developing therapies for neuroinflammation and central nervous system disorders. The Company’s lead clinical program i ...Company Presentation
- CNS/Neurological
-
Company PresentationModel Medicines is an AI-native biotechnology company developing first-in-class small-molecule therapeutics by targeting conserved biological choke points that drive disease across multiple indication ...Company Presentation
- Infectious Diseases
-
As biotech funding dynamics evolve, investors are seeking capital models that reward commercial discipline and strategic partnership. Traditional venture pathways are giving way to hybrid approaches — ...Educational Session Pompeii Ballroom
-
Company PresentationRecall Therapeutics is pioneering a breakthrough platform for memory restoration in Alzheimer’s disease, oncology-related cachexia, and aging-associated sarcopenia.Company Presentation
- CNS/Neurological
-
Company PresentationSoligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics bus ...Company Presentation
- Orphan/Rare Diseases
-
Company PresentationSynklino is a clinical stage biotechnology company pioneering transformative therapies for solid organ transplantation. Our first-in-class breakthrough drug candidate, SYN002, is a therapeutic fusion ...Company Presentation
- Infectious Diseases
-
Company PresentationCanary Cure Therapeutics is a late-stage preclinical biotechnology company pioneering a paradigm shift in the treatment of obesity and metabolic diseases. While first-generation therapies have validat ...Company Presentation
- Metabolic Diseases
-
Company PresentationGuidant Bio (aka Sonnet Bio) is a clinical stage oncology company with differentiated dual-cytokine and next gen ADC assets built on our clinically validated proprietary tumor-targeting delivery platf ...Company Presentation
- Oncology
-
More than a third of U.S. licensing deals this year have involved assets sourced from China and investment is adjusting in response. As deal activity accelerates, regulatory scrutiny has intensified. ...Educational Session Pompeii Ballroom
-
Company PresentationDuo Oncology is an oncology company reimagining chemotherapy, a foundational treatment for metastatic cancer. Its lead program, DUO-207, consolidates multi-drug chemotherapy regimens into a single, po ...Company Presentation
- Oncology
-
Company PresentationVincere Biosciences is a Boston-based, AI-powered biotechnology company developing first-in-class therapeutics that target the fundamental mechanisms of aging and disease. By enhancing mitophagy—the c ...Company Presentation
- CNS/Neurological
-
Company PresentationSebastian BioPharma is a preclinical oncology company developing tumor-targeted, multi-pathway therapeutics for colorectal cancer and other immunotherapy-resistant solid tumors. Our lead program uses ...Company Presentation
- Oncology
-
Company PresentationJecho Laboratories is a clinical-stage company focusing in oncology across fusion proteins, ADCs, TCEs, and bsAbs.Company Presentation
- Oncology
-
In a capital-constrained environment, Enveda distinguished itself by securing high-quality funding at a rapid clip—closing a $150M Series D in late 2025 to achieve "unicorn" status just five years aft ...Educational Session Pompeii Ballroom
-
Company PresentationKaliVir Immunotherapeutics is a clinical-stage biotechnology company at the forefront of developing next-generation oncolytic immunotherapies. By harnessing the unique advantages of the vaccinia platf ...Company Presentation
- Oncology
-
Company PresentationImmunophotonics, Inc. is developing an innovative therapy to prevent cancer from coming back after local tumor destruction (ablation) therapy. Advancements in cancer treatment, such as precision medic ...Company Presentation
- Oncology
-
Company PresentationImmuneOnco is a Hong Kong-listed (Stock Code: HK.1541) clinical-stage biotechnology company dedicated to discovering and developing immunotherapies for the treatment of cancer and other diseases. Timd ...Company Presentation
- Oncology
)
March 2-3, 2026 | Miami Beach
)
March 2-3, 2026 | Miami Beach
)
March 2-3, 2026 | Miami Beach
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
